|
|
|
|
|
|
By Outsourced Pharma | Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities and Threats (CMOT) Report” to our readers. The report identifies CDMOs that might be impacted by key events affecting their clients, including company acquisitions, product acquisitions and licenses, product approvals, late clinical product terminations, and FDA rejections. | |
|
|
| Getting To The Heart Of CDMO Tech Transfer Excellence | Article | Bora Pharmaceuticals | Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to CDMO success. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Bioprocess Online: |
|
|
|